Thursday Morning Headlines

Yesterday was dominated by Biogen's news on their Alzheimer drug, but there was other news including Sarepta getting slapped with a clincial hold, Gilead CEO stepping down and, although not Life Science related, Facebook getting crushed after their earnings.  Here is what I'm reading: Yesterday afternoon Eisai & Biogen Revealed Promising Alzheimer’s Data But Questions … Continue reading Thursday Morning Headlines

Tuesday Morning Reads

Good morning and happy Tuesday.  Here is what I am reading this morning: How United Technologies wants to use 3-D-printed lungs to end transplant shortages (MIT Technology Review). T cell 'backpacks' boost immune attack against solid tumors in mice. These nanoparticle backpacks would attach to T cells and hopefully make it easier to translate to … Continue reading Tuesday Morning Reads